Brensocatib Reduced Symptom Burden, Neutrophil Serine Proteases Activity in Bronchiectasis

Abstracts presented during the CHEST annual meeting, held in Chicago, Illinois, October 19-22, 2025, showed the efficacy of brensocatib (Brinsupr; Insmed Incorporated Investor Relations) in reducing the activity of neutrophil serine proteases…